Current translational and clinical challenges in advanced hepatocellular carcinoma
Authors
Frizziero, MelissaMcNamara, Mairead G
Lamarca, Angela
Pihlak, Rille
Kurup, Roopa
Hubner, Richard A
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester,Issue Date
2020
Metadata
Show full item recordCitation
Frizziero M, McNamara MG, Lamarca A, Pihlak R, Kurup R, Hubner RA. Current Translational And Clinical Challenges In Advanced Hepatocellular Carcinoma. Curr Med Chem. 2020.Journal
Current Medicinal ChemistryDOI
10.2174/0929867327666200422143847PubMed ID
32321391Additional Links
https://dx.doi.org/ 10.2174/0929867327666200422143847Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.2174/0929867327666200422143847
Scopus Count
Collections
Related articles
- Immune checkpoint blockade in advanced hepatocellular carcinoma: an update and critical review of ongoing clinical trials.
- Authors: Harding JJ
- Issue date: 2018 Sep
- Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
- Authors: Choi JY
- Issue date: 2011
- Considerations of heterogeneity in clinical trials for hepatocellular carcinoma.
- Authors: Liu TH, Shao YY, Lu LC, Shen YC, Hsu C, Lin ZZ, Hsu CH, Cheng AL
- Issue date: 2019 Jul
- [Clinical advances in targeted therapy and immunotherapy for hepatocellular carcinoma].
- Authors: Zhang DZ, Niu JQ
- Issue date: 2019 Nov 20
- Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma.
- Authors: Liu Z, Lin Y, Zhang J, Zhang Y, Li Y, Liu Z, Li Q, Luo M, Liang R, Ye J
- Issue date: 2019 Nov 4